Trial Profile
Safety and efficacy of S 38093 versus placebo in patients with Alzheimer's Disease. An international, multi-centre, randomised, double-blind, placebo-controlled phase IIa study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Nov 2012
Price :
$35
*
At a glance
- Drugs S 38093 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 28 Apr 2012 Additional primary endpoints identified as reported by European Clinical Trials Database.
- 28 Apr 2012 Additional trial locations added as reported by European Clinical Trials Database.
- 28 Apr 2012 Actual end date 13 Sep 2010 added as reported by European Clinical Trials Database.